Shah A - Search Results

1

Enhanced antibacterial effect of erythromycin in the presence of 3,5-dibenzoyl-1,4-dihydropyridines.

Gunics G, Motohashi N, Molnár J, Farkas S, Kawase M, Saito S, Shah A. Gunics G, et al. Among authors: shah a. Anticancer Res. 2001 Jan-Feb;21(1A):269-73. Anticancer Res. 2001. PMID: 11299745

2

Interaction between 3,5-diacetyl-1,4-dihydropyridines and ampicillin, and erythromycin on different E. coli strains.

Gunics G, Farkas S, Motohashi N, Shah A, Harsukh G, Kawase M, Molnár J. Gunics G, et al. Among authors: shah a. Int J Antimicrob Agents. 2002 Sep;20(3):227-9. doi: 10.1016/s0924-8579(02)00159-0. Int J Antimicrob Agents. 2002. PMID: 12385704

3

3,5-diacetyl-1,4-dihydropyridines: synthesis and MDR reversal in tumor cells.

Shah A, Gaveriya H, Motohashi N, Kawase M, Saito S, Sakagami H, Satoh K, Tada Y, Solymosi A, Walfard K, Molnar J. Shah A, et al. Anticancer Res. 2000 Jan-Feb;20(1A):373-7. Anticancer Res. 2000. PMID: 10769682

4

3,5-dibenzoyl-1,4-dihydropyridines: synthesis and MDR reversal in tumor cells.

Kawase M, Shah A, Gaveriya H, Motohashi N, Sakagami H, Varga A, Molnár J. Kawase M, et al. Among authors: shah a. Bioorg Med Chem. 2002 Apr;10(4):1051-5. doi: 10.1016/s0968-0896(01)00363-7. Bioorg Med Chem. 2002. PMID: 11836114

5

Tumour-specific cytotoxicity and MDR-reversal activity of dihydropyridines.

Engi H, Sakagami H, Kawase M, Parecha A, Manvar D, Kothari H, Adlakha P, Shah A, Motohashi N, Ocsovszki I, Molnár J. Engi H, et al. Among authors: shah a. In Vivo. 2006 Sep-Oct;20(5):637-43. In Vivo. 2006. PMID: 17091771 Free article.

6

Multidrug resistance reversal by 3-formylchromones in human colon cancer and human mdr1 gene-transfected mouse lymphoma cells.

Baráth Z, Radics R, Spengler G, Ocsovszki I, Kawase M, Motohashi N, Shirataki Y, Shah A, Molnár J. Baráth Z, et al. Among authors: shah a. In Vivo. 2006 Sep-Oct;20(5):645-9. In Vivo. 2006. PMID: 17091772 Free article.

7

Biological activity of 6,12-dihydro-1-benzopyrano[3,4-b][1,4]benzothiazin-6-ones.

Shah A, Naliapara Y, Sureja D, Motohashi N, Kurihara T, Kawase M, Satoh K, Sakagami H, Molnár J. Shah A, et al. Anticancer Res. 1998 Jan-Feb;18(1A):61-3. Anticancer Res. 1998. PMID: 9568056

8

6,12-dihydro-1-benzopyrano[3,4-b][1,4]benzothiazin-6-ones: synthesis and mdr reversal in tumor cells.

Shah A, Naliapara Y, Sureja D, Motohashi N, Kawase M, Miskolci C, Szabo D, Molnár J. Shah A, et al. Anticancer Res. 1998 Jul-Aug;18(4C):3001-4. Anticancer Res. 1998. PMID: 9713499

9

3,5-Dibenzoyl-4-(3-phenoxyphenyl)-1,4-dihydro-2,6-dimethylpyridine (DP7) as a new multidrug resistance reverting agent devoid of effects on vascular smooth muscle contractility.

Saponara S, Kawase M, Shah A, Motohashi N, Molnar J, Ugocsai K, Sgaragli G, Fusi F. Saponara S, et al. Among authors: shah a. Br J Pharmacol. 2004 Feb;141(3):415-22. doi: 10.1038/sj.bjp.0705635. Epub 2004 Jan 12. Br J Pharmacol. 2004. PMID: 14718255 Free PMC article.

10

Tumor-specific cytotoxicity of 3,5-dibenzoyl-1,4-dihydropyridines.

Morshed SR, Hashimoto K, Murotani Y, Kawase M, Shah A, Satoh K, Kikuchi H, Nishikawa H, Maki J, Sakagami H. Morshed SR, et al. Among authors: shah a. Anticancer Res. 2005 May-Jun;25(3B):2033-8. Anticancer Res. 2005. PMID: 16158941 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,801 results

Search Page

Filters